Abstract
Fabry disease is a rare X-linked lysosomal storage disorder that causes renal failure, cardiomyopathy, and premature stroke. Enzyme-replacement therapy (ERT) with recombinant agalsidase has been shown to stabilize renal function is some patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
